Talphera (TLPH) Shares Issued (2010 - 2011)
Talphera (TLPH) posted Shares Issued of $19.6 million for Q4 2011, up 173.61% on a QoQ basis from $7.2 million in Q4 2010, and up 173.61% year-over-year from $7.2 million in Q4 2010.
Powered by 
Analysis
Talphera (TLPH) Shares Issued (2010 - 2011) Analysis & Trends
Talphera has reported Shares Issued for 2 years, with the latest figure at $19.6 million in Q4 2011.
- On a quarterly basis, Shares Issued rose 173.61% year-over-year to $19.6 million in Q4 2011; TTM through Dec 2011 was $19.6 million, a 173.61% increase from a year earlier, with the FY2011 full-year figure at $19.6 million, up 173.61% from the prior year.
- Shares Issued was $19.6 million for Q4 2011 at Talphera, up from $7.2 million in the prior quarter.
- The five-year high for Shares Issued was $19.6 million in Q4 2011, with the low at $7.2 million in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.58 Bn | 192.59 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.17 Bn | 176.99 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.59 Bn | 122.74 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.61 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.24 Bn | 55.05 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.29 Bn | 49.15 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 32.96 Bn | 29.65 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.94 Bn | 30.66 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.38 Bn | 29.38 Bn | 1.16 Mn | - |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | - |